Hysteroscopic and Immunohistochemical Findings in Type I and Type II Endometrial Carcinomas
- 1 May 2001
- journal article
- Published by Elsevier in The Journal of the American Association of Gynecologic Laparoscopists
- Vol. 8 (2) , 222-230
- https://doi.org/10.1016/s1074-3804(05)60582-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Theories of Endometrial Carcinogenesis: A Multidisciplinary ApproachLaboratory Investigation, 2000
- p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial CancerGynecologic Oncology, 1999
- Distinctive p53 and mdm2 Immunohistochemical Expression Profiles Suggest Different Pathogenetic Pathways in Poorly Differentiated Endometrial CarcinomaInternational Journal of Gynecological Pathology, 1998
- Clear cell carcinoma arising in an endometrial polypGynaecological Endoscopy, 1998
- Stage IA Uterine Serous CarcinomaThe American Journal of Surgical Pathology, 1997
- Polypectomy and endometrial resection in postmenopausal patientsThe Journal of the American Association of Gynecologic Laparoscopists, 1997
- Uterine papillary serous carcinoma evolves via a p53-driven pathwayHuman Pathology, 1996
- Endometrial Papillary Serous Carcinoma: Patterns of Spread and TreatmentClinical Obstetrics and Gynecology, 1996
- Expression and mutation analysis of the p53 gene in uterine papillary serous carcinomaCancer, 1995
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983